<DOC>
	<DOCNO>NCT00838708</DOCNO>
	<brief_summary>Pruritus essential feature diagnosis atopic dermatitis may play important part disease progression . Itching significant impact quality life AD sufferer , particular night-time itch leading sleep disturbance subsequent poor daytime performance . The objective study determine whether SRD174 Cream safe effective therapy moderate severe pruritus associate atopic dermatitis .</brief_summary>
	<brief_title>Phase IIa Safety Efficacy Study SRD174 Cream Patients With AD-associated Pruritus</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pruritus</mesh_term>
	<criteria>Males female age 18 year moderate severe AD pruritus Written sign date informed consent Satisfactory medical assessment clinically relevant abnormality Subject active pruritic AD covering body surface area ( BSA ) &gt; 20 % Subject severe AD define IGA score 4 Subject current recurrent skin disease ( except AD ) could affect site application action , absorption disposition investigational product , clinical , laboratory assessment . Subjects unstable uncontrolled medical condition could require intensive treatment course study . Subject know suspect intolerance hypersensitivity Investigational product state ingredient . Subject medical psychiatric condition laboratory abnormality may increase risk associate trial participation investigational product administration may interfere interpretation trial result , judgment investigator , would make subject inappropriate entry trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>